1Sudoh T,Kangawa K, Minamino N,et al. A neunatriuretic peptide in Porcine brain. Nature, 1988 ;332:78 -81.
2DeBold AJ.Borenstein HB, Veress AT, et al. A rpid and poent natrindic response to intravenous injection of atrial myocandial extract in rats. Life Sci, 1981 ;28: 89 - 94.
3Nakao K, Ogawa Y, Suga S, et al, Molecular biology and biochemistry of the natriuretic peptide system Ⅰ: natriuretic peptides. J Hypertens, 1992; 10:907 - 912
5Salomon P,Przew locka- Kosmala M,Orda A et al. Plasma levels of brain natriuretic peptide, cyclic3'5'- guanosine monophosphate, endothelin - 1 and noradrenaline in patients with chronic congestive heart failure. Pol Arch Med Wewn,2003 ;109( 1 ):43 -48.
6Mukoyama A, Nakao K, HoSoda K, et al. Eur J Clin- Inyest, 1998 ;28 ( 8 ) :636 - 642.
8Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B - type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002 ;347(3) : 161-167.
9Maisel A, B - type natriuretic peptide 1 evels : a potential novel "white Count" for congestive heart failure. J Card Fail,2001 ;7(2) : 183 - 193.
10Kelly R,Struthers AD. Are natriuretic Peptide clinically useful as markers Of heart failure? Ann Clin Biochem ,2001 ;38 (5) :575 - 583.
二级参考文献10
1Maeda K,Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin - 6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol, 2000;36 (5):1581～1593
2Cargill RI, Barr CS, Coutie WJ, et al. C-type natriuretic peptide levels in corpulmonale and in congestive heart failure. Thorax, 1994;49(12): 1247～1249
3Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B - natriuretic as a rapid,point-of- care test for screening patients udnergoing echocardiography to determine left ventricular dysfunction. Am Heart J ,20011; 141 (3) :367～374
4Kawai K, Hata K,Tokaoka H, et al. Plasma brain natriuretic peptide as a nove therapeutic indicator in idiopathic dilated cardiomyopathy during beta- blocker therapy:a potential of hormone- guided treatment. Am Heart J ,2001; 141 (6) :925 ～932
5Trovate GM,Carpinteri G.Effects of atria1 fibrillation on the increase of atria1 natruretic peptide in congestive heart failure.Recenti Prog Med,1994;85:570
6Muscholl MW,Schunkert H,Muders T,et al.Neurohormone activity and left ventricular geometry in patients with essential arterial hypertension.Am Heart J,1998;135:58
